| Original language | English (US) |
|---|---|
| Pages (from-to) | 265-272 |
| Number of pages | 8 |
| Journal | Journal of Psychoactive Drugs |
| Volume | 31 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jan 1 1999 |
Funding
tThe authors would like to thank the Bureau of Substance Abuse Services. Massachusetts Department of Public Health, for use of their MIS data collecti on instruments and data on out -of-Boston utili zati on by Boston clients. This study was supported by Center for Substance Abuse Treatment Cooperative Agreement 1-U88-T I 00022. • Professor of Health Care and Operations Management, School of Management. Boston University. • *Director of Addiction Services. Department of Psychiatry, Massachusetts General Hospital: Associate Professor of Psychiatry, Harvard Medical School, Boston. •••social Science Analys t. Office of Evaluation, Scientific Analysis and Synthesis, Center for Substance Abuse Treatment. Substance Abuse and Mental Health Services Administration, Rockville. Maryland. • • • • Director of Substance Abuse Services, Department of Medicine. Tewksbury Hospital, Massachusetts Department of Public Health. ••••• Heller School for Social Po licy. Brandeis University, Boston. ••••••Bureau of Substance Abuse Services. Massachusetts Department of Public Health. •••••••Executive Director, Health and Addictions Research Inc. ••••••••Director, Department of Public Health, Seattle-Kings County. Please address correspondence and reprint requests to Michael Shwartz, Ph.D., School of Management, Boston University, 595 Commonwealth Avenue, Boston, Massachusetts 022 I 5.
ASJC Scopus subject areas
- Medicine (miscellaneous)
- General Psychology